Researchers hope that changes to total hip BMD will get approval from the FDA as a surrogate endpoint for clinical trials of ...
Photo MRI lumbosacral spine pathology. Radiologist indicated on possible pathology or disease of image of spine lumbosacral MRI such as sciatica, protrusion of disc, pinched nerve, hernia, stenosis ...
MONTREAL, QUEBEC — Improvements in bone mineral density (BMD) after 2 years of osteoporosis drug therapy could serve as a surrogate biomarker for decreased fracture risk, a new multidrug meta-analysis ...
Incidence of nonvertebral fractures significantly decreased as T-scores improved during treatment with denosumab for osteoporosis. While many chronic conditions have guidance avaiable with clinical ...
Bone mineral density at the femoral neck and total hip is a potential surrogate for fracture risk in clinical trials of osteoporosis drugs, according to findings presented at the American Society for ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window AUSTIN, Texas – ...
MedPage Today on MSN
Drug Combo Fails to Cut Fracture Risk in Brittle Bone Disease
Among 350 adults with the condition, also known as brittle bone disease, the incidence of image-confirmed fractures didn't significantly differ between groups over a median follow-up of 55 months ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results